title: Initial experience with intravenous pentobarbital sedation for children undergoing MRI at a tertiary care pediatric hospital: the learning curve.
abstract: OBJECTIVE
  Our purpose is to describe the initial experience with intravenous pentobarbital sedation in children undergoing MRI at a tertiary pediatric hospital to identify errors associated with inexperience.
  
  
  METHODS
  The study included the first 100 children sedated with intravenous pentobarbital prior to magnetic resonance examination at a tertiary pediatric hospital. The protocol included a maximum dose of 6 mg/kg administered in three divided doses with the total dose not to exceed 200 mg. Flow sheets documenting vital signs, administered drug doses, and adverse reactions were maintained contemporaneous to sedation.
  
  
  RESULTS
  Sedation was successful in 92 children. Of the eight children who failed sedation, three were at least 12 years old and three weighed more than 50 kg. chi2 tests identified significantly greater failure rates in children older than 11 years or weight greater than 50 kg. Two children had prolonged sedation after the maximum suggested dose was exceeded.
  
  
  CONCLUSIONS
  The success rate was good, but could have been improved by restricting the use of pentobarbital to children less than 12 years of age and weighing less than 50 kg. Radiologists inexperienced with intravenous sedation should strictly observe the maximum suggested dose of pentobarbital to prevent prolonged sedation.
authors.affiliation: Arkansas Children's Hospital, Little Rock 72202, USA. GreenbergSBruce@exchange.UAMS.edu
authors.forename: S B
authors.initials: SB
authors.lastname: Greenberg
authors.forename: R C
authors.initials: RC
authors.lastname: Adams
authors.forename: C L
authors.initials: CL
authors.lastname: Aspinall
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000009:adverse effects; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging; D010424:Pentobarbital / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D006993:Hypnotics and Sedatives; D010424:Pentobarbital